Alembic Pharma Q1 net jumps 45%

Our Bureau Ahmedabad | Updated on January 18, 2018 Published on July 29, 2016

Vadodara-based Alembic Pharmaceuticals Ltd has posted a net profit of Rs 102 crore for the first quarter ended June 30, 2016, showing 45 per cent rise over Rs 70.17 crore reported in the corresponding period last year.

Net sales increased by 25 per cent to Rs 736 crore.

Commenting on the results, Pranav Amin, Managing Director, said: "We continue to invest in R&D for future growth. Alembic USA was successfully established and has launched 23 products in the market."

The company has reported 72 per cent growth in international formulations business to Rs 308 crore. Whereas the India branded business grew 6 per cent to Rs 277.74 crore.

Alembic Pharmaceuticals shares were trading up by 2.5 per cent at Rs 628.05 on the National Stock Exchange.

Published on July 29, 2016
This article is closed for comments.
Please Email the Editor